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a b s t r a c t
Five mouse anti-human butyrylcholinesterase (BChE) monoclonal antibodies bind tightly to native hu-
man BChE with nanomolar dissociation constants. Pairing analysis in the Octet system identified the
monoclonal antibodies that bind to overlapping and independent epitopes on human BChE. The
nucleotide and amino acid sequences of 4 monoclonal antibodies are deposited in GenBank. Our goal was
to determine which of the 5 monoclonal antibodies recognize BChE in the plasma of animals. Binding of
monoclonal antibodies 11D8, B2 18e5, B2 12e1, mAb2 and 3E8 to BChE in animal plasma was measured
using antibody immobilized on Pansorbin cells and on Dynabeads Protein G. A third method visualized
binding by the shift of BChE activity bands on nondenaturing gels stained for BChE activity. Gels were
counterstained for carboxylesterase activity. The three methods agreed that B2 18e5 and mAb2 have
broad species specificity, but the other monoclonal antibodies interacted only with human BChE, the
exception being 3E8, which also bound chicken BChE. B2 18e5 and mAb2 recognized BChE in human,
rhesus monkey, horse, cat, and tiger plasma. A weak response was found with rabbit BChE. Monoclonal
mAb2, but not B2 18e5, bound pig and bovine BChE. Gels stained for carboxylesterase activity confirmed
that plasma from humans, monkey, pig, chicken, and cow does not contain carboxylesterase, but plasma
from horse, cat, tiger, rabbit, guinea pig, mouse, and rat has carboxylesterase. Rabbit plasma carbox-
ylesterase hydrolyzes butyrylthiocholine. In conclusion monoclonal antibodies B2 18e5 and mAb2 can be
used to immuno extract BChE from the plasma of humans, monkey and other animals.
© 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Butyrylcholinesterase (BChE; EC 3.1.1.8) is a serine esterase that
catalyzes the hydrolysis of acetylcholine, butyrylcholine, benzoyl-
choline, indoxyl acetate, p-nitrophenyl acetate, phenyl acetate,
alpha-naphthyl acetate, aspirin, procaine, succinyldicholine,
mivacurium, cocaine, heroin, irinotecan, bambuterol and octanoyl
ghrelin [1e4]. Some of these esters are used as drugs to treat
various human conditions. BChE also serves as a stoichiometric
bioscavenger for organophosphorus pesticides and nerve agents,
thus protecting acetylcholinesterase from irreversible inhibition by
these toxic compounds [5].
Many drugs are synthesized as esters to neutralize their charge,
thus allowing the drug to be absorbed through the gut and through
cell membranes including cells in the brain. The esterified drugmay
be a prodrug that requires hydrolysis of the ester bond to become
the active drug. For example, the antiasthma prodrug bambuterol is
hydrolyzed to the active drug terbutaline by BChE [6]. Other ester
drugs are detoxified by BChE. For example, BChE hydrolyzes
cocaine to the pharmacologically inactive metabolites, ecgonine
methyl ester and benzoic acid [7e9]. New drugs are tested in
Abbreviations: HuBChE, human butyrylcholinesterase; BSA, bovine serum al-
bumin; CES, carboxylesterase; U, units of activity.
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animals before they are tested in humans. Standard laboratory
animals including the mouse, rat, guinea pig, and monkey have
levels of BChE in plasma that are not representative of the level of
BChE in human plasma. The rat has 30-fold less plasma BChE
compared to humans. Rhesus monkey has 2e3 fold higher levels of
BChE in plasma than humans. Another difference between animals
and humans is that mouse, rat, and guinea pig have carbox-
ylesterase in plasma, whereas humans and monkeys have none [4].
The plasma carboxylesterase in animals degrades drug esters
rapidly, giving an inaccurate pharmacokinetic profile for drug
metabolism in humans. The plasma carboxylesterase knockout
mouse, ES1/ (Jackson Laboratory stock number 014096), can be
used as a model for how humans metabolize an ester drug [10,11].
Knowledge of the identity of the esterase involved in meta-
bolism of a drug is important because it leads to an understanding
of individual differences in response to drugs. The atypical and si-
lent variants of human BChE do not hydrolyze succinylcholine and
mivacurium; consequently people with these genetic variants are
unable to breathe for up to 2 h from a dose intended to paralyze for
3 min [12]. More than 70 variants of human BChE have been
recognized [13]. Animal studies that aim to identify the role of BChE
in drug metabolism may benefit by using an immobilized antibody
to capture BChE. The captured BChE has activity and can be used
directly to measure the role of BChE in ester hydrolysis, as we have
done for octanoyl ghrelin [14]. Mrvova et al. produced two mono-
clonal antibodies in BChE knockout mice that recognize BChE in
mouse, rat and dog plasma [15].
In a previous report [16] we characterized 5 mouse anti-human
BChE monoclonal antibodies. We reported similar nanomolar
binding affinities for all 5 monoclonal antibodies, but variable
performance in their ability to immunopurify BChE from human
plasma. Octet pairing analysis was carried out by immobilizing pure
human BChE on a chip followed by measurement of the change in
the interference pattern when antibody flowed over the chip.
Pairing analysis showed that two pairs of antibodies, mAb2 and B2
12e1, as well as mAb2 and 3E8, bound to independent epitopes on
human BChE and were therefore useful in sandwich assays. We
deposited the nucleotide and amino acid sequences of 4 mono-
clonal antibodies in GenBank. The goal of the present work was to
identify the monoclonal antibodies that recognize BChE in the
plasma of animals. We describe 5 monoclonal antibodies to human
BChE, two of which have broad specificity enabling them to
recognize BChE in the blood of human, monkey, horse, cat, and
tiger.
2. Materials and methods
2.1. Reagents
2.1.1. Pansorbin cells 1 g (Calbiochem #507862) coated with 1 ml of
rabbit anti-mouse IgG H þ L (Jackson ImmunoResearch #315-001-
003)
Dynabeads Protein G (Life Technologies #10004D). Immuno-
Pure immobilized Protein G (Pierce #20398). Human plasma Na
Citrate pooled from 10 donors (UNMC blood bank); rhesus monkey
plasma Na Heparin and horse serum (Atlanta Biologicals); cat
plasma Na Citrate (Pel-Freeze); Bengal Tiger plasma EDTA antico-
agulant (Omaha Henry Doorly Zoo); New Zealand white rabbit
plasma Na Heparin, porcine serum, and rat serum (RJO Biologicals);
guinea pig plasma Na Heparin and mouse strain 129 serum
(Taconic); chicken plasma Na Heparin (Innovative Research Inc.);
bovine calf serum (General Scientific Lab). Acetylthiocholine iodide,
butyrylthiocholine iodide and ethopropazine hydrochloride
(SigmaeAldrich).
2.1.2. Monoclonal antibodies to HuBChE
Mouse anti-human BChE monoclonal antibodies were from the
following sources. Monoclonal 3E8 was purchased from Thermo
Scientific Pierce (HAH 002-01-02); the original 3E8 monoclonal
was made in Denmark [17]. Hybridoma cell line 11D8 was a gift
from Dr. Eric Krejci and Dr. Anna Hrabovska [18]. We purified the
11D8 monoclonal from culture medium on Protein G-Sepharose.
Hybridoma cell lines B2 18e5 and B2 12e1 were a gift from Dr.
Stephen Brimijoin [19]. The cells, having been stored at 80 C for
30 years, failed to grow but their RNA was still intact. Syd Labs Inc
(Natick, MA) made the B2 18e5 and B2 12e1 monoclonal anti-
bodies by recombinant DNA methods using mRNA as a template to
make cDNA, followed by ligation of the cDNA into vectors that
contained the constant regions, coexpression of the light and heavy
chains in Chinese Hamster Ovary cells, and purification on protein
A-Sepharose. Ascites fluid from B2 18e5 and B2 12e1 was available
for comparison to the recombinant antibodies. The mAb2 mono-
clonal was made in France [20]. We purified mAb2 from ascites
fluid.
2.2. Nucleotide and amino acid sequences of monoclonal antibodies
The nucleotide and amino acid sequences of mouse anti human
BChE monoclonal antibodies are deposited in the NCBI databank
under accession numbers KJ141199 and KJ141200 for mAb2,
KT189143 and KT189144 for B2 18e5, KT189145 and KT189146 for
B2 12e1, and KT189147 and KT189148 for 11D8. Use of these
monoclonal antibodies for immunoextraction of BChE from human
plasma is described in Ref. [16].
2.3. BChE activity
BChE activity was measured in 0.1 M potassium phosphate pH
7.0 at 25 C with 1 mM butyrylthiocholine iodide in the presence of
0.5 mM 5,5’-dithiobis(2-nitrobenzoic acid) on a Gilford spectro-
photometer interfaced to a MacLab data recorder (ADinstruments,
Inc.). For example, a 4 ml cuvette received 1.91 ml buffer, 0.05 ml of
20 mM DTNB in buffer, 0.02 ml of 0.1 M butyrylthiocholine dis-
solved in water, and 0.02 ml plasma. The increase in absorbance at
412 nm was recorded for 1 min and converted to micromoles
butyrylthiocholine hydrolyzed using the extinction coefficient
13,600 M1 cm1 [21]. Units (U) of activity are expressed as mi-
cromoles per min.
2.4. Immunoadsorbance of BChE to monoclonal antibodies
immobilized on pansorbin
Pansorbin® cells are an inexpensive alternative to Dynabeads-
Protein G for assessing species selectivity of 5 monoclonal anti-
bodies. Pansorbin® cells are heat-killed, formalin-fixed Staphylo-
coccus aureus cells that bear a high cell-surface density of protein A.
The Pansorbin assay was performed as described by Brimijoin
et al. [19]. The effectiveness of Pansorbin for binding mouse
monoclonal antibodies is enhanced when Pansorbin cells are
coated with rabbit anti-mouse IgG. Therefore, the first step in the
protocol was to incubate 1 g of washed Pansorbin cells suspended
in 9 ml of 50 mM TrisHCl pH 7.4 containing 0.1% BSA with 1 ml of
1 mg/ml rabbit anti-mouse IgG at 37 C overnight. A 0.1 ml aliquot
of rabbit anti-mouse IgG Pansorbin cell suspensionwaswashed and
incubated with 1 mg monoclonal in a total volume of 0.2 ml over-
night. The control incubation contained Pansorbin cells and buffer,
but no monoclonal. Unbound monoclonal was washed off. The
washed Pansorbin complex was incubated overnight at room
temperature on a rotating mixer with plasma or serum containing
13.5 milliunits of BChE supplemented with 50 mM TrisHCl pH 7.4/
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0.1% BSA to total 0.2 ml. Plasma or serum was from human, rhesus
monkey, horse, domestic cat, Bengal tiger, New Zealand white
rabbit, pig, guinea pig, mouse, chicken, or adult cow. Rat plasma
and bovine serum were added to the cells without buffer.
The Pansorbin cells were pelleted by centrifugation at 5000 rpm
for 4 min. The supernatant was assayed for unbound BChE activity.
The pellets were washed twice with 1 ml buffer and finally with
1 ml of 0.1 M potassium phosphate, pH 7.0. The activity of BChE
bound to Pansorbin cells was determined by measuring the yellow
color that developed after addition of 1 ml Ellman reagent (1 mM
butyrylthiocholine, 0.5 mM 5,5’-dithiobis(2-nitrobenzoic acid) in
0.1 M potassium phosphate pH 7.0) to the washed pellet. The re-
action was stopped after 10 min by addition of 20 ml of 2.0 mM
ethopropazine, a specific inhibitor of BChE activity. After centrifu-
gation at 12,000 rpm for 10 min to pellet the turbidity from Pan-
sorbin cells, absorbance of the supernatant was read in the Gilford
spectrophotometer at 412 nm. Fig. 1A illustrates antibodies and
BChE bound to Pansorbin and detection of bound BChE by mea-
surement of bound BChE activity.
2.5. Dynabeads-Protein G for immunopurification of BChE from
plasma or serum
Immunopurification of HuBChE from human plasma in a single
step was developed by Sporty et al. to enable mass spectrometry
diagnosis of exposure to chemical nerve agents [22]. In the present
work we used the Sporty protocol to compare 5 monoclonal anti-
bodies for ability to extract BChE from the plasma or serum of
animals. We evaluated the quantity of BChE bound by comparing
BChE activity in the unbound fraction to BChE activity in plasma
before treatment with Dynabeads.
In brief, 100 ml of Dynabeads-Protein G suspension was washed
three times with 200 ml of PBS, followed by incubation overnight
with 20 mg of monoclonal antibody in 0.4 ml PBS containing 0.05%
Tween-20. The Dynabead complexwaswashed twicewith 200 ml of
triethanolamine buffer (0.2 M triethanolamine, 0.025% NaN3, pH
7.8), before the complex was crosslinked with 200 ml of dimethyl
pimelimidate (5.4 mg/ml) in triethanolamine buffer for 30min. The
crosslinking solution was discarded and residual agent was inac-
tivated by incubating the beads for 15 min in 20 mM TrisHCl pH 7.5.
Beads were washed 3 times with 200 ml of PBS, 0.05% Tween-20
before they were incubated with 0.5 ml human, monkey, horse,
cat, guinea pig, mouse and chicken plasma or serum, and 5 ml
rabbit, pig, rat or bovine plasma or serum overnight at room
temperature in a rotating mixer. We did not have enough tiger
plasma to assay binding of tiger BChE to Dynabeads. BChE activity
assays were used to evaluate the quantity of BChE bound. Fig. 1B
shows BChE enzyme captured by anti-BChE antibody immobilized
on Dynabeads Protein G and detection of bound BChE by mea-
surement of bound BChE activity.
2.6. Nondenaturing polyacrylamide gel electrophoresis
Animal plasma or serum samples (5 ml) were incubated 3 h at
25 C with or without 10 ml of monoclonal B2 18e5 (0.9 mg/ml) or
10 ml of mAb2 (0.6 mg/ml) for 3 h at 25 C before they were diluted
with an equal volume of 50% glycerol, 0.1% bromphenol blue.
Samples were loaded on nondenaturing 4e30% gradient poly-
acrylamide gels and electrophoresed at 250 V constant voltage for
20 h at 4 C. The gels were stained for BChE activity by the method
of Karnovsky and Roots [23]. The staining solution contained
180 ml of 0.2 M maleic acid adjusted to pH 6.0 before use, 15 ml of
0.1 M sodium citrate, 30 ml of 0.03 M CuSO4, 30 ml of water, 30 ml
of 5 mM potassium ferricyanide, and 0.18 g butyrylthiocholine io-
dide to make 2 mM butyrylthiocholine. Gels were incubated in the
buffer for 2 h with gentle shaking until brown-red bands appeared.
Gels were counterstained for carboxylesterase (CES) activity by
incubating them in 100 ml of 50 mM TrisHCl pH 8.0 to which was
added 50 mg of alpha-naphthylacetate in 1 ml ethanol to make
2.7 mM, and 50mg of solid Fast Blue RR [4]. Green bands developed
within a few minutes.
2.7. Comparison of BChE amino acid sequences
The protein sequence of HuBChE was compared with the BChE
sequences of rhesus monkey, horse, cat, Bengal tiger, pig, guinea
pig, mouse, rat, chicken, and cow using BLASTP 2.2.30þ [24]. The
sequence comparison results are presented as percent identity.
3. Results
3.1. Butyrylcholinesterase activity in animal plasma or sera
BChE activity varied widely between species. Table 1 shows the
highest BChE activity in Rhesus monkey plasma, similar BChE ac-
tivities in human, horse, and mouse, low activity in the cat, tiger,
rabbit, pig, and chicken, and barely detectable BChE activity in rat
plasma and adult bovine serum.
Fig. 1. Schemes for antibody binding to Pansorbin and Dynabeads Protein G. A) Protein A on the surface of Pansorbin is coated with anti-mouse IgG to enhance binding of mouse
anti-BChE monoclonal antibody. The pansorbin antibody complex is incubated with plasma to allow capture of BChE by the anti-BChE IgG. The bound BChE retains enzyme activity
and is detected by hydrolysis of butyrylthiocholine. B) Protein G on the surface of Dynabeads is crosslinked to anti-BChE monoclonal antibody. The Dynabeads Protein G antibody
complex is incubated with plasma to capture BChE. Bound BChE is detected by measuring BChE activity in the Dynabeads complex, or alternatively be measuring the loss of BChE
activity from plasma.
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3.2. B2 18e5 and mAb2 recognize butyrylcholinesterase from
different species
The reactivity of five anti-human BChE monoclonal antibodies
with BChE in the blood of animals was compared by measuring
immunoabsorbance to monoclonal antibodies immobilized on
Pansorbin cells or Dynabeads Protein G. The percent BChE bound to
Pansorbin cells was calculated by measuring the BChE activity
bound to Pansorbin cells. The percent BChE bound to Dynabeads
was calculated by comparing BChE activity in the unbound super-
natant to activity in plasma/serum. The results in Fig. 2A for assays
performed with Pansorbin are similar to the results in Fig. 2B for
assays with Dynabeads Protein G, with some exceptions. The Pan-
sorbin assay used a constant quantity of BChE activity (13.5 milli-
units) whereas the Dynabeads Protein G assay used a constant
volume of plasma (0.5 ml) per incubation reaction, except for
rabbit, pig, rat, and cow where the volume of plasma was 5 ml.
Fig. 2A shows that in the Pansorbin assay all 5 monoclonal anti-
bodies bound 45e60% of the 13.5 milliunits of BChE activity in
human plasma. Fig. 2B shows that in the Dynabeads assay B2 18e5
and B2 12e1 captured nearly 100% of the BChE activity in 0.5 ml
human plasma, while mAb2 and 3E8 captured 60e70%, and 11D8
captured 10% of the BChE in human plasma. Monoclonal antibodies
11D8 and B2 12e1 bound human BChE exclusively, whereas 3E8
bound human and chicken BChE. Chicken BChE was captured by
20 mg 3E8 in the Dynabeads assay, but not by 1 mg 3E8 in the
Pansorbin assay.
Monoclonal antibodies B2 18e5 and mAb2 had the broadest
species specificity, capturing BChE in human, rhesus monkey,
horse, cat, and rabbit plasma/serum. B2 18e5 and mAb2 also
captured BChE in the plasma of Bengal tiger in the Pansorbin assay.
We have no data for tiger BChE in the Dynabeads assay because the
quantity of tiger plasma available to uswas limited. The BChE in pig,
guinea pig, mouse, rat, chicken, and cow plasma/serum was not
recognized by B2 18e5. However, pig and cow BChE were captured
by mAb2, though the quantity captured was low because these
animals have low BChE activity in plasma. The low BChE activity in
pig and cow plasma resulted in large values for the standard
deviation.
BChE activity without and with monoclonal antibody was
visualized on nondenaturing gels stained for BChE activity. In Fig. 3,
5 ml of plasma or serum samples were loaded per lane. Band in-
tensities correlate with BChE activities reported in Table 1. Animal
plasma or sera that have BChE activity of 0.4e5 U/ml (human,
monkey, horse, cat, tiger, guinea pig and mouse) have strong bands
of BChE activity in Fig. 3A lanes 1, 3, 5, 7, 9, 15 and 17. However,
animal plasma or sera that have BChE activity of 0.04e0.3 U/ml
(rabbit, pig, rat, chicken, and cow) haveweak bands of BChE activity
in Fig. 3A lanes 11, 13, 19, 21, and 23.
The tetramer band of human BChE, C4, has a molecular weight
of 340,000 Da. The dimer band, C3, is composed of two identical
BChE subunits. However the dimer band, C2, consists of one BChE
subunit and one albumin molecule linked via a disulfide bond [25].
Fig. 3A shows that human, horse, cat, tiger, and mouse have a C2
band, but monkey and guinea pig do not. The monomer band, C1, is
thought to be a partially proteolysed BChE that is missing the 40
residue-tetramerization domain at the BChE C-terminal.
BChE from human, rhesus monkey, horse, cat, tiger, guinea pig,
and mouse resolved into monomer, dimer and tetramer bands on
the nondenaturing gels in Fig. 3A, whereas BChE from rabbit, rat,
and chicken merely showed tetramer bands. Minor BChE bands are
probably present in the plasma of rabbit, rat, and chicken, but their
concentration is below the limit of detection. The dominant form of
BChE in human, monkey, horse, cat, tiger, rabbit, mouse, rat, and
chicken plasma is a tetramer. However, the dominant form of BChE
in guinea pig plasma is a dimer. Bands of BChE activity in human,
monkey, horse, and mouse plasma that migrate more slowly than
the BChE tetramer C4 are called storage bands because they are not
present in freshly drawn plasma, but appear in plasma that has
been stored.
Incubation of plasmawithmonoclonal B218e5 in Fig. 3A shifted
the bands of BChE activity to slower migrating forms that represent
a complex of BChE with antibody. Band shifts are clearly visible for
human, monkey, horse, and cat plasma incubated with B2 18e5
(Fig. 3A lanes 2, 4, 6, 8), but are less evident for tiger plasma (Fig. 3A
lane 10). The BChE band for rabbit plasma disappeared in the
sample incubated with B2 18e5 (Fig. 3A lane 12). In contrast, band
shifts are not seen for B2 18e5 incubated with plasma from pig,
guinea pig, mouse, rat, chicken and cow, supporting the conclusion
that B2 18e5 does not bind to BChE from these species. The non-
denaturing gel in Fig. 3A supports the Pansorbin and Dynabeads
results for monoclonal B2 18e5 by visually demonstrating the
interaction of antibody with BChE from selected species.
The gel in Fig. 3A was counterstained with alpha-
naphthylacetate and Fast Blue RR to reveal carboxylesterase activ-
ity in Fig. 3B. Carboxylesterase activity (CES) is seen as a dark green
band above albumin. Horse, cat, tiger, rabbit, guinea pig, mouse,
and rat have carboxylesterase in plasma, but human, monkey, pig,
chicken, and cow have no carboxylesterase in plasma.
Binding of 3E8 to chicken BChE is visualized in Fig. 4 where the
band for chicken BChE in lane 3 disappears following incubation
with 3E8 (lane 4). The chicken BChE complex with 3E8 is assumed
to have become too large to enter the gel. In contrast, incubation of
chicken plasma with monoclonal B2 18e5 (Fig. 3A lane 22) had no
effect on the mobility of chicken BChE, supporting the conclusion
that chicken BChE does not bind to B2 18e5. BChE activity bands in
human plasma shift to slower migrating forms following incuba-
tionwith 3E8 (Fig. 4 lane 2); the broad smear of BChE activity in the
stacking gel (Fig. 4 lane 2) indicates that the human BChE complex
with 3E8 is heterogeneous and very large.
Table 2 compares the reactivity of monoclonals B2 18e5 and
mAb2 with BChE in the plasma of 12 species as measured in 3
different assays.
3.3. BChE amino acid sequence comparisons
We used BLASTP 2.2.30 þ to compare the protein sequence of
human BChE with BChE from rhesus monkey, horse, cat, Bengal
tiger, rabbit, pig, guinea pig, mouse, rat, chicken, and cow. The
BLAST analysis revealed sequence identities of 72e96% (Table 3).
The BChE sequences of twelve species were aligned in
Supplementary Fig. S5. Residues important for enzyme hydrolysis
are present in all species. The low plasma BChE activity in some
Table 1
BChE activity in plasma or serum.
Species BChE activity, U/ml a
Human (Homo sapiens) plasma 2.50 ± 0.02
Rhesus monkey (Macaca mulatta) plasma 5.00 ± 0.18
Horse (Equus caballus) serum 2.26 ± 0.10
Cat (Felis catus) plasma 0.40 ± 0.01
Bengal Tiger (Panthera tigris tigris) serum 0.60 ± 0.01
Rabbit (Oryctolagus cuniculus) plasma 0.13 ± 0.03
Pig (Sus scrofa domesticus) serum 0.19 ± 0.01
Guinea pig (Cavia porcellus) plasma 1.26 ± 0.06
Mouse (Mus musculus) serum 2.51 ± 0.11
Rat (Rattus norvegicus) plasma 0.058 ± 0.012
Chicken (Gallus gallus) plasma 0.30 ± 0.02
Cow (Bos taurus) serum 0.05 ± 0.02
a BChE activity was assayed in quadruplicate.
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species could be the consequence of amino acid sequence differ-
ences in regions not recognized as being important for catalysis or
stability. Differences in the promoter and in the sequence around
the translation start site could also explain low plasma BChE
activity.
Amino acid sequence identity does not predict which animal
BChE will be recognized by monoclonal antibodies to human BChE.
For example, though horse BChE and bovine BChE protein
Fig. 2. Reactivity of anti-HuBChE monoclonal antibodies with BChE in the plasma or sera from various animal species. A) measured with Pansorbin cells; B) measured with
Dynabeads protein G.
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sequences are 90% identical to human BChE, monoclonal B2 18e5
binds horse BChE but not bovine BChE.
4. Discussion
4.1. Mammals with very low BChE activity in plasma
All the animals in the present study have one BCHE gene and
mRNA encoding the BChE protein. BChE activity varies 100-fold
from a low of 0.05 U/ml in rat to 5.0 U/ml in rhesus monkey
plasma. A similar species difference in plasma BChE activity was
reported by Augustinsson, who assayed activity with butyrylcho-
line by the Warburg method [26]. Plasma of cow, goat and sheep
had barely detectable levels of BChE activity, while plasma of rabbit,
rat and swine had slightly higher but still 20-fold lower BChE ac-
tivity compared to human plasma.
A generally accepted function of BChE is to detoxify poisons that
are eaten or inhaled. Animals with the lowest plasma BChE levels
might be expected to have compensating plasma carboxylesterase
activity. Rabbit and rat have carboxylesterase in plasma, but pig,
chicken, and cow have no carboxylesterase in plasma. Another
function of BChE is hydrolysis of the neurotransmitter acetylcho-
line. BChE acts as an independent and complementary modulator
of acetylcholine levels at the mouse neuromuscular junction [27].
4.2. Monoclonal antibodies that recognize BChE in animal plasma
Monoclonal antibodies B2 18e5 and B2 12e1 were created by
Brimijoin et al. inmouse against human BChE [19]. They tested their
monoclonal antibodies in the Pansorbin assay for ability to bind
BChE in the plasma of various species and found that B2 18e5 binds
BChE in human, squirrel monkey, dog, cat, and horse plasma, but
does not bind BChE in guinea pig, chicken and rat plasma. B2 18e5
was weak in binding BChE in rabbit plasma. B2 12e1 bound only
human BChE. In a second study, B2 12e1 bound serum BChE in
higher primates in the order of affinity by species:
man > chimpanzee ¼ pygmy chimpanzee > gorilla >> orangutan >
gibbon [28] with Kd values ranging from 2.8 nM to 74 nM. In
contrast, B2 18e5 discriminated only marginally between the BChE
of apes and man [28].
The B2 18e5 monoclonal we tested was expressed in Chinese
Hamster Ovary cells. The B2 12e1 monoclonal was expressed in
human HEK 293 cells. Our results agree with those of Brimijoin
et al. [19]. In conclusion the B2 18e5 and B2 12e1 monoclonal
antibodies produced by recombinant DNA methods have the same
species specificity as the monoclonal antibodies secreted by mouse
hybridoma cells.
Monoclonal mAb2 was created in mouse against human BChE
[20]. Similar to B2 18e5, monoclonal mAb2 has broad species
specificity. Pairing analysis on the Octet Red96 system showed that
mAb2 and B2 18e5 bind to overlapping but not identical epitopes
on HuBChE [16]. B2 18e5 paired with mAb2 when B2 18e5 was the
capture antibody, but not in the reverse formatwhenmAb2was the
capture antibody. The observation that mAb2 binds to an epitope
that is not completely identical to the epitope recognized by B2
18e5 justifies our finding that their species specificities have some
Fig. 3. Nondenaturing polyacrylamide gradient gels of plasma/serum incubated without or with monoclonal B2 18e5, indicated by ewithout and by þwith B2 18e5. A) stained for
BChE activity with butyrylthiocholine iodide; B) counterstained with alpha-naphthylacetate and Fast Blue RR to reveal carboxylesterase activity (CES) and albumin. The arrow
indicates the direction of migration toward the anode. The minor components of human plasma BChE are used as markers, where C1 is monomeric BChE, C2 is a dimer composed of
one BChE subunit covalently bound to one albumin molecule, C3 is a BChE dimer, and C4 is the BChE tetramer.
H. Peng et al. / Chemico-Biological Interactions 243 (2016) 82e90 87
differences. Monoclonal mAb2, but not B2 18e5, binds BChE in the
plasma of cow and pig.
None of the monoclonal antibodies in the present report
recognized mouse BChE. A unique strategy for producing anti-
mouse BChE antibodies in mice was introduced by Hrabovska
et al. [18]. They immunized BChE knockout mice with recombinant
mouse BChE and obtained highly efficient monoclonal antibodies
that bind mouse BChE with Kd values in the nanomolar range [15].
No other laboratory has generated a monoclonal to mouse BChE.
4.3. Carboxylesterase in rabbit plasma hydrolyzes
butyrylthiocholine
Rabbit plasma has two prominent bands of butyrylthiocholine
hydrolase activity on a nondenaturing gel. The band near the top of
the separating gel is BChE (P21927 UniProtKB). The band that mi-
grates far into the gel is rabbit plasma carboxylesterase (CES). As a
general rule carboxylesterases hydrolyze neutral esters but not
positively charged esters. The carboxylesterase in rabbit plasma is an
exception because it hydrolyzes the positively charged butyrylth-
iocholine. A previous report named the rabbit plasma carbox-
ylesterase “monomeric BChE” [29]. However, Jbilo et al. concluded
that “monomericBChE” in rabbit plasma is carboxylesterase [30]. The
rabbit plasma carboxylesterasedidnot bind to procainamide-affinity
gel, it was not inhibited significantly by the specific BChE inhibitors
eserine and iso-OMPA, and it preferred indoxyl acetate as a substrate.
The existence of only one BCHE gene in the rabbit genome means
there is no support for twopharmacologically distinct BChE proteins.
Our results support the conclusion of Jbilo et al. [30] that the
butyrylthiocholine hydrolase that migrates adjacent to albumin in
Fig. 3 (lanes 11 and 12) is rabbit carboxylesterase. The carbox-
ylesterases in horse, cat, tiger, rabbit, guinea pig, mouse, and rat
plasma consistently migrate adjacent to albumin and stain with
alpha-naphthylacetate. Bahar et al. also agreed that this second
band of butyrylthiocholine hydrolase activity is the activity of
rabbit carboxylesterase [31]. We found that monoclonal antibodies
B2 18e5 and mAb2 shifted the position of rabbit BChE, but not
rabbit CES, supporting the conclusion that the butyrylthiocholine
hydrolase labeled BChE in Fig. 3 lanes 11 and 12 is BChE, while the
band labeled CES is carboxylesterase.
Additional support for our conclusion that CES in Fig. 3 lanes 11
and 12 is carboxylesterase comes from studies of the hereditary
deficiency of atropine esterase in rabbits. Rabbits deficient in
atropine esterase do not have a band of butyrylthiocholine hydro-
lase activity adjacent to albumin on a nondenaturing gel [30]. The
atropine esterase in rabbit serum is a carboxylesterase with a
molecular weight of 65,000, similar to the molecular weight of
albumin. The purified atropine esterase (carboxylesterase) has low
but detectable activity with the positively charged esters acetyl-
choline, butyrylcholine, and benzoylcholine [32]. Carboxylesterases
from rabbit liver also hydrolyze butyrylthiocholine though activity
is detected only with 10e100 mM butyrylthiocholine concentra-
tions and not with the 1 mM concentration that is standard for
BChE activity assays [33]. Carboxylesterases are encoded by mul-
tiple genes. The NCBI database lists 25 genes for rabbit carbox-
ylesterases all located on adjacent sites within chromosome 5-
NC_013673.1. The carboxylesterase in rabbit plasma is encoded by
a different gene than the carboxylesterases in rabbit liver.
Fig. 4. Chicken BChE binds monoclonal antibody 3E8. Plasma (5 mL) was incubated
without or with monoclonal 3E8 (10 mL), indicated by e without and by þ with 3E8.
Following incubation, the samples were subjected to nondenaturing gradient gel
electrophoresis. The gel was stained for BChE activity. Lane 1, human plasma. Lane 2,
human plasma þ3E8. Lane 3, chicken plasma. Lane 4, chicken plasma þ3E8. The 4%
stacking gel contains a large-sized complex of human BChE and 3E8 (lane 2).
Table 2
Species specificity of monoclonal antibodies B2 18e5 and mAb2 for BChE assayed on Pansorbin, Dynabeads, and nondenaturing PAGE.
Pansorbin B2 18-5 Dynabeads B2 18-5 PAGE B2 18-5 Pansorbin mAb2 Dynabeads mAb2 PAGE mAb2
Human þþ þþ þþ þþ þþ þþ
Monkey þþ þþ þþ þþ þþ þþ
Horse þþ þþ þþ þþ þþ þþ
Cat þþ þþ þþ þþ þþ þþ
Tiger þþ þ þþ þ
Rabbit þ þ þ þ þ e
Pig e e e þþ þ e
Guinea pig e e e e e e
Mouse e e e e e e
Rat e e e e e e
Chicken e e e e e e
Cow e e e þþ þ e
þþindicates strong binding; þweak binding; - no binding to monoclonal.
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